文献速递临床试验与 GCP流行病学与生物统计

儿童药物难治性癫痫的手术治疗

Surgery for Drug-Resistant Epilepsy in Children.
PubMed 文献 · N Engl J Med · 2017-01-01

这项单中心随机试验纳入116例18岁及以下药物难治性癫痫患者,比较脑外科手术联合药物治疗与单纯药物治疗。12个月时手术组无癫痫发作率77%,单纯药物组7%(P<0.001),手术组在行为与生活质量评分上更优,但严重不良事件发生率为33%,其中偏瘫26%。

要点

  • 12个月无癫痫发作:手术组44例(77%)vs 单纯药物组4例(7%),P<0.001。
  • 手术组严重不良事件19例(33%),偏瘫15例(26%)。
  • 行为与生活质量评分改善手术组优于单纯药物组,智力商数无显著差异。

核心结论

  • 在单中心试验中,接受癫痫手术的儿童和青少年12个月无癫痫发作率显著高于继续单纯药物治疗者,行为与生活质量评分也更优。
  • 手术导致了与脑切除区域相关的预期神经功能缺损。

研究设计与样本

  • 单中心随机试验,纳入116例18岁及以下药物难治性癫痫患者。
  • 随机分为手术组57例(针对癫痫病因的脑外科手术联合适当药物治疗)和单纯药物组59例(仅药物治疗,并列入手术等待名单)。

主要发现

  • 12个月无癫痫发作:手术组44例(77%)vs 单纯药物组4例(7%)(P<0.001)。
  • 海牙癫痫严重程度量表评分从基线至12个月变化组间差异19.4(95%CI 15.8至23.1;P<0.001),利于手术。
  • 儿童行为量表评分变化组间差异13.1(95%CI 10.7至15.6;P<0.001),利于手术。
  • 儿科生活质量量表评分变化组间差异21.9(95%CI 16.4至27.6;P<0.001),利于手术。
  • Vineland社会成熟度量表社会商变化组间差异4.7(95%CI 0.4至9.1;P=0.03),利于手术;Binet-Kamat智力商数变化组间差异2.5(95%CI -0.1至5.1;P=0.06),无显著差异。

关键数值与推荐

  • 主要结局为12个月无癫痫发作。
  • 手术组严重不良事件19例(33%),包括偏瘫15例(26%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neurosurgical treatment may improve seizures in children and adolescents with drug-resistant epilepsy, but additional data are needed from randomized trials. METHODS: In this single-center trial, we randomly assigned 116 patients who were 18 years of age or younger with drug-resistant epilepsy to undergo brain surgery appropriate to the underlying cause of epilepsy along with appropriate medical therapy (surgery group, 57 patients) or to receive medical therapy alone (medical-therapy group, 59 patients). The patients in the medical-therapy group were assigned to a waiting list for surgery. The primary outcome was freedom from seizures at 12 months. Secondary outcomes were the score on the Hague Seizure Severity scale, the Binet-Kamat intelligence quotient, the social quotient on the Vineland Social Maturity Scale, and scores on the Child Behavior Checklist and the Pediatric Quality of Life Inventory. RESULTS: At 12 months, freedom from seizures occurred in 44 patients (77%) in the surgery group and in 4 (7%) in the medical-therapy group (P<0.001). Between-group differences in the change from baseline to 12 months significantly favored surgery with respect to the score on the Hague Seizure Severity scale (difference, 19.4; 95% confidence interval [CI], 15.8 to 23.1; P<0.001), on the Child Behavior Checklist (difference, 13.1; 95% CI, 10.7 to 15.6; P<0.001), on the Pediatric Quality of Life Inventory (difference, 21.9; 95% CI, 16.4 to 27.6; P<0.001), and on the Vineland Social Maturity Scale (difference, 4.7; 95% CI, 0.4 to 9.1; P=0.03), but not on the Binet-Kamat intelligence quotient (difference, 2.5; 95% CI, -0.1 to 5.1; P=0.06). Serious adverse events occurred in 19 patients (33%) in the surgery group, including hemiparesis in 15 (26%). CONCLUSIONS: In this single-center trial, children and adolescents with drug-resistant epilepsy who had undergone epilepsy surgery had a significantly higher rate of freedom from seizures and better scores with respect to behavior and quality of life than did those who continued medical therapy alone at 12 months. Surgery resulted in anticipated neurologic deficits related to the region of brain resection. (Funded by the Indian Council of Medical Research and others; Clinical Trial Registry-India number, CTRI/2010/091/000525 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

引用

  1. Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for Drug-Resistant Epilepsy in Children. N Engl J Med. 2017. PMID: 29069568. doi:10.1056/NEJMoa1615335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。